| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |